Skip to content
★ Sign in to follow
Total declarations
8
Companies
3
▲ Purchases (5 ops.)
€253k
▼ Sales (0 ops.)
—

Latest filing published 31 Jul 2026 for Akeso, Inc..

Insider track record

Disclosed buys
5
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Tan Bo: trading record in brief

This profile gathers the share dealings of Tan Bo across 3 companies, led by 3SBio Inc., Everest Medicines Ltd. and Akeso, Inc. In total, 8 filings cover trades dated from 28 June 2018 to 24 July 2026.

Purchases make up the whole of the open-market record (5 purchases, €253k). The totals do not cover 4 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 1 purchase and no sales.

Most recently, on 31 July 2026, the filings show an open-market purchase in Akeso, Inc. The median gap between a trade and its publication by HKEX is 7 days. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from HKEX. Past trades are no guide to future returns.

Companies and markets linked to Tan Bo

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    DirectorExecutivesAkeso, Inc.
    0HKEX
    15,000 sharesShareXHKGHKEX:DA20260730E00562
    Canonical exit: 22 Oct 2026 (T+90)

1 of 1 declaration